Sexual activity and prostate cancer risk in men diagnosed at a younger ageThe rs10993994 risk allele for prostate cancer results in clinically relevant changes in microseminoprotein-beta expression in tissue and urineCommon breast cancer-predisposition alleles are associated with breast cancer risk in BRCA1 and BRCA2 mutation carriersDuctal approaches to assessment and management of women at high risk for developing breast cancerGenome-wide association study in BRCA1 mutation carriers identifies novel loci associated with breast and ovarian cancer riskAssociation between BRCA1 and BRCA2 mutations and survival in women with invasive epithelial ovarian cancer.Germline BRCA mutations are associated with higher risk of nodal involvement, distant metastasis, and poor survival outcomes in prostate cancer.DNA-Repair Defects and Olaparib in Metastatic Prostate CancerA germline mutation in the androgen receptor gene in two brothers with breast cancer and Reifenstein syndromeLow-penetrance susceptibility to breast cancer due to CHEK2(*)1100delC in noncarriers of BRCA1 or BRCA2 mutationsThe potential value of microseminoprotein-beta as a prostate cancer biomarker and therapeutic targetOverexpression of RAD51 occurs in aggressive prostatic cancerMultiple newly identified loci associated with prostate cancer susceptibilityInterim analysis of the incidence of breast cancer in the Royal Marsden Hospital tamoxifen randomised chemoprevention trialCross-Cancer Genome-Wide Analysis of Lung, Ovary, Breast, Prostate, and Colorectal Cancer Reveals Novel Pleiotropic AssociationsGenome-Wide Meta-Analyses of Breast, Ovarian, and Prostate Cancer Association Studies Identify Multiple New Susceptibility Loci Shared by at Least Two Cancer TypesCross Cancer Genomic Investigation of Inflammation Pathway for Five Common Cancers: Lung, Ovary, Prostate, Breast, and Colorectal CancerTelomere structure and maintenance gene variants and risk of five cancer typesPALB2, CHEK2 and ATM rare variants and cancer risk: data from COGSGenetic variation in prostate-specific antigen-detected prostate cancer and the effect of control selection on genetic association studiesIdentification of seven new prostate cancer susceptibility loci through a genome-wide association studySeven prostate cancer susceptibility loci identified by a multi-stage genome-wide association studyIdentification of 23 new prostate cancer susceptibility loci using the iCOGS custom genotyping array.Association Between Telomere Length and Risk of Cancer and Non-Neoplastic Diseases: A Mendelian Randomization Study.Multiple novel prostate cancer predisposition loci confirmed by an international study: the PRACTICAL Consortium.Radiogenomics: radiobiology enters the era of big data and team science.Processing of radical prostatectomy specimens for correlation of data from histopathological, molecular biological, and radiological studies: a new whole organ technique.Predicting the likelihood of carrying a BRCA1 or BRCA2 mutation: validation of BOADICEA, BRCAPRO, IBIS, Myriad and the Manchester scoring system using data from UK genetics clinics.Proteomic analysis of nipple aspirate fluid throughout the menstrual cycle in healthy pre-menopausal women.A pilot study of compositional analysis of the breast and estimation of breast mammographic density using three-dimensional T1-weighted magnetic resonance imagingTEAD1 and c-Cbl are novel prostate basal cell markers that correlate with poor clinical outcome in prostate cancer.Evaluation of association of HNF1B variants with diverse cancers: collaborative analysis of data from 19 genome-wide association studies.Assessing the usefulness of a novel MRI-based breast density estimation algorithm in a cohort of women at high genetic risk of breast cancer: the UK MARIBS studyMutation analysis of the MSMB gene in familial prostate cancer.Prostate cancer risk regions at 8q24 and 17q24 are differentially associated with somatic TMPRSS2:ERG fusion status.Cowden syndrome and Lhermitte-Duclos disease in a family: a single genetic syndrome with pleiotropy?Germline PTEN mutations in Cowden syndrome-like families.Is no news good news? Inconclusive genetic test results in BRCA1 and BRCA2 from patients and professionals' perspectivesDevelopments in Clinical Practice: Follow up Clinic for BRCA Mutation Carriers: a Case Study Highlighting the "Virtual Clinic".Baseline results from the UK SIGNIFY study: a whole-body MRI screening study in TP53 mutation carriers and matched controls.
P50
Q21558581-66D266CD-2C8F-4220-99CF-5B61591F8F89Q21562160-A7B82E08-5D86-4FA1-90E7-529A1824E4D2Q24655824-FEB62D57-C17A-4FAF-B663-6BC003485C8DQ24794407-4D655D6E-2A4C-495A-8FD1-2723993F58DAQ27008356-7C19FFCF-08CB-4685-8EE2-3C503B23EC7DQ27851709-8035CCC0-57C1-4A63-B5C8-E69215578B84Q27852185-96BDAFB8-6108-4F87-81C7-7DDFA31A6CF2Q27853235-CBCD035A-F297-4CF8-BF18-59F62017988EQ28208102-F42F4018-8D29-43E6-B52B-6BAD60E28159Q28215462-8D45BF89-FFFF-4A37-B87B-1C111A94F68AQ28259937-B8E0DA7A-7AC1-47A1-80E9-5D454B0A0E83Q28267299-CAB0BD6F-7F95-4FB1-9598-3E5D940792AAQ28268180-32628E6F-5295-4C60-8174-66485C09144FQ28277066-6E4E1076-AABF-442B-9EA1-7D86CAE08C59Q28388475-4535B5F7-10B4-4095-B240-77E5C270BA25Q28388497-F297750B-65EB-4DA2-ADB1-5865A7FDB1ADQ28396029-E7B8B7A1-BD76-4CB0-8877-2C2982A4E103Q28397509-9F7994A8-2BDD-40D3-9B85-9B18B615A708Q28584533-46E0D54C-ED2F-40DF-B685-A82D8D9B946AQ28943405-2FBA2FF9-1611-4A3F-92EB-EF08311595D5Q29417022-7BE3570B-16A5-41B7-BF51-ABF3E2C639D4Q29417074-91172A00-7470-43A8-997C-D22E8EDCF510Q29417155-FD2DA06F-7209-45FF-B4D7-CD9CCF912E24Q30253080-C502BC35-483A-4A60-96EE-6FF143202FC7Q30491647-E4CDD28E-B549-4042-B82D-2985C3BF24CEQ30833608-15E3B73E-D9D1-404D-B74B-C95D4A3AB2C8Q30988445-FD1B92DC-0A43-4FBD-B0C0-409630918865Q31152672-336C12C8-37FB-49A0-8288-EC26B3250935Q33261340-59ABD62A-AD85-4441-ACDC-05C978478635Q33366184-85FA5DAD-9F64-4D2F-A763-C673EE724C82Q33383797-5DD42BEE-DEBC-47A9-9B8D-926BB092CBA4Q33595844-DDA9AEC5-E0E6-495F-9852-E6D27654B091Q33627147-2E7D166C-7882-4049-847F-2BFC352250D8Q33630836-B5E864C2-3060-4398-8496-2EAD5B861E66Q33640983-E2361CB4-F0F0-4E90-B62F-AB8D7CAD09E4Q33674349-A7DA95DC-F253-47C6-924E-69FFED0263D5Q33681468-48DCA55C-80C3-4F2F-B2EA-4FE91BEE9C36Q33706730-FED0FCF7-09F4-4A22-9D9D-2B58213080DCQ33732294-98D32AEC-87C4-4CB5-85DA-4F2B351E2ACFQ33844055-380C7C6F-00EE-4E6E-9AC4-5A630432C32B
P50
description
British geneticist
@en
British geneticist
@en-ca
British geneticist
@en-gb
Brits geneticus
@nl
geneticista británica
@pt
genetista britainiarra
@eu
genetista britannica
@it
genetista britànica
@ca
genetista británica
@es
généticienne britannique
@fr
name
Rosalind A Eeles
@ast
Rosalind A Eeles
@es
Rosalind A Eeles
@sl
Rosalind Eeles
@en
Rosalind Eeles
@nl
type
label
Rosalind A Eeles
@ast
Rosalind A Eeles
@es
Rosalind A Eeles
@sl
Rosalind Eeles
@en
Rosalind Eeles
@nl
altLabel
Eeles R
@en
Eeles RA
@en
Eeles
@en
Professor Rosalind Eeles
@en
R. A. Eeles
@en
RA Eeles
@en
Rosalind A. Eeles
@en
prefLabel
Rosalind A Eeles
@ast
Rosalind A Eeles
@es
Rosalind A Eeles
@sl
Rosalind Eeles
@en
Rosalind Eeles
@nl
P1006
P1015
P214
P227
P244
P269
P1006
P1015
P106
P1412
P2080
P21
P213
0000 0000 3120 8067
P214
P227
P244
P269
P31
P496
0000-0002-3698-6241
P569
1959-01-01T00:00:00Z
1959-04-10T00:00:00Z
P735
P7859
lccn-n93047722